Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
A new tool to measure the burden of Crohn's disease and its treatment: Do patient and physician perceptions match
Inflammatory Bowel Disease, 09/03/09
Siegel CA et al. – Two questions using the feeling thermometer provide a quick and accurate assessment of the burden of CD on patients. Physicians' perception of the burden of disease was similar to their patients.
Related Articles
A Case-Control Study on Risk Factors of Osteoporosis in Patients with Crohn's Disease
Archives of Iranian Medicine, 11/13/09
Relevance Score: 69%
Impact of disease activity on resting energy expenditure in children with inflammatory bowel disease
Clinical Nutrition, 11/18/09
Relevance Score: 68%
Gastrointestinal stromal tumor causing small bowel intussusception in a patient with Crohn's disease
World Journal of Gastroenterology, 11/13/09
Relevance Score: 68%
Pathogenesis of inflammatory bowel disease (IBD)
The Internet Journal of Gastroenterology, 11/13/09
Relevance Score: 68%
Methotrexate for maintenance of remission in Crohn's disease
Cochrane Reviews, 10/27/09
Relevance Score: 68%
Today in Inflammatory Bowel Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Polymorphisms of the apoptosis-associated gene DP1L1 (deleted in polyposis 1-like 1) in colon cancer and inflammatory bowel disease
Journal of Cancer Research & Clinical Oncology, 12/03/09
Review article: influenza A (H1N1) virus in patients with inflammatory bowel disease
Alimentary Pharmacology and Therapeutics, 12/03/09
chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease
Alimentary Pharmacology and Therapeutics, 12/03/09
Sponsor
Article Search
Sponsor


See Latest Articles


